Advertisement

Pediatric Cardiology

, Volume 34, Issue 1, pp 194–197 | Cite as

Hemangioendothelioma: A Rare Case of a Primary Intracardiac Tumor

  • Andrea BeatonEmail author
  • Trevor Kuttler
  • Ali Hassan
  • Dilip S. Nath
  • Christine Reyes
  • Richard A. Jonas
  • Gerard R. Martin
Case Report

Abstract

Kaposiform hemangioendothelioma (KH) is a rare tumor of vascular origin that commonly affects the cutaneous tissues of the extremities. It can, however, affect the abdomen, thorax, head, or neck. Compared with juvenile hemangiomas, which tend to regress, KH tumors are locally aggressive and usually persist. Associated morbidity and mortality rates range from 12 to 30 % and typically are related to either compressive effects on surrounding vital structures or effects of the Kasabach–Merritt phenomenon [10, 11, 13]. To our knowledge, this report is the first to describe KH presenting as a primary intracardiac tumor.

Keywords

Pediatric cardiology Cardiac tumor Pericardial effusion 

References

  1. 1.
    Beaubien ER, Ball NJ, Storwick GS (1998) Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol 38:799–802PubMedCrossRefGoogle Scholar
  2. 2.
    Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM (1997) Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J 134:1107–1114PubMedCrossRefGoogle Scholar
  3. 3.
    Burke A, Johns JP, Virmani R (1990) Hemangiomas of the heart: a clinicopathologic study of ten cases. Am J Cardiovasc Pathol 3:283–290PubMedGoogle Scholar
  4. 4.
    Chen RL, Chang PY, Hsu YH, Chang YH, Peng HC (2006) Recurrent life-threatening hemothorax in an infant with pleurocutaneous kaposiform hemangio-endothelioma. J Pediatr Hematol Oncol 28:630–632PubMedCrossRefGoogle Scholar
  5. 5.
    Cooper JG, Edwards SL, Holmes JD (2002) Kaposiform haemangioendothelioma: case report and review of the literature. Br J Plast Surg 55:163–165PubMedCrossRefGoogle Scholar
  6. 6.
    Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HP (2005) D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 18:1454–1460PubMedCrossRefGoogle Scholar
  7. 7.
    Enjolras O, Mulliken JB, Wassef M, Frieden IJ, Rieu PN, Burrows PE, Salhi A, Leaute-Labreze C, Kozakewich HP (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235PubMedCrossRefGoogle Scholar
  8. 8.
    Fernandez Y, Bernabeu-Wittel M, Garcia-Morillo JS (2009) Kaposiform hemangioendothelioma. Eur J Intern Med 20:106–113PubMedCrossRefGoogle Scholar
  9. 9.
    Haisley-Royster C, Enjolras O, Frieden IJ, Garzon M, Lee M, Oranje A, de Laat PC, Madern GC, Gonzalez F, Frangoul H, Le Moine P, Prose NS, Adams DM (2002) Kasabach–Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462PubMedCrossRefGoogle Scholar
  10. 10.
    Harper L, Michel JL, Enjolras O, Raynaud-Mounet N, Riviere JP, Heigele T, De Napoli-Cocci S (2006) Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach–Merritt phenomenon using alpha-interferon. Eur J Pediatr Surg 16:369–372PubMedCrossRefGoogle Scholar
  11. 11.
    Hauer J, Graubner U, Konstantopoulos N, Schmidt S, Pfluger T, Schmid I (2007) Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach–Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 49:852–854PubMedCrossRefGoogle Scholar
  12. 12.
    Hu B, Lachman R, Phillips J, Peng SK, Sieger L (1998) Kasabach–Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol 20:567–569PubMedCrossRefGoogle Scholar
  13. 13.
    Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW (2004) Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559–568PubMedCrossRefGoogle Scholar
  14. 14.
    Mackie AS, Kozakewich HP, Geva T, Perez-Atayde AR, Mulliken JB (2005) Vascular tumors of the heart in infants and children: case series and review of the literature. Pediatr Cardiol 26:344–349PubMedCrossRefGoogle Scholar
  15. 15.
    Mentzel T, Mazzoleni G, Dei Tos AP, Fletcher CD (1997) Kaposiform hemangioendothelioma in adults: clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol 108:450–455PubMedGoogle Scholar
  16. 16.
    Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE (1997) Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 100:1377–1386PubMedCrossRefGoogle Scholar
  17. 17.
    Vin-Christian K, McCalmont TH, Frieden IJ (1997) Kaposiform hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol 133:1573–1578PubMedCrossRefGoogle Scholar
  18. 18.
    Vogel RM, Keohane M (1967) Renal vascular abnormalities in acute pancreatitis. Arch Intern Med 119:610–616PubMedCrossRefGoogle Scholar
  19. 19.
    Zukerberg LR, Nickoloff BJ, Weiss SW (1993) Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach–Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321–328PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Andrea Beaton
    • 1
    Email author
  • Trevor Kuttler
    • 2
  • Ali Hassan
    • 3
  • Dilip S. Nath
    • 1
  • Christine Reyes
    • 1
  • Richard A. Jonas
    • 1
  • Gerard R. Martin
    • 1
  1. 1.Children’s National Medical CenterWashingtonUSA
  2. 2.Walter Reed National Military Medical CenterBethesdaUSA
  3. 3.Chest Disease HospitalKuwait CityKuwait

Personalised recommendations